Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Early changes of acetylcholinesterase activity and insulin system in the brain of the streptozotocin- intracerebroventricularly treated rat model of sporadic Alzheimer's disease (CROSBI ID 580977)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Knezović, Ana ; Marjanović, Ana Marija ; Osmanović-Barilar, Jelena ; Bradamante, Vlasta ; Riederer, Peter ; Šalković-Petrišić, Melita Early changes of acetylcholinesterase activity and insulin system in the brain of the streptozotocin- intracerebroventricularly treated rat model of sporadic Alzheimer's disease // Neurodegenerative diseases / Nitsch, Roger M. ; Fisher, Abraham ; Windisch, Manfred et al. (ur.). S.Karger, Medical and Scientific Publisher, 2011

Podaci o odgovornosti

Knezović, Ana ; Marjanović, Ana Marija ; Osmanović-Barilar, Jelena ; Bradamante, Vlasta ; Riederer, Peter ; Šalković-Petrišić, Melita

engleski

Early changes of acetylcholinesterase activity and insulin system in the brain of the streptozotocin- intracerebroventricularly treated rat model of sporadic Alzheimer's disease

Introduction Sporadic Alzehimer’s disease (sAD) is associated with central cholinergic deficit and impaired insulin receptor (IR) signaling both in humans and its animal model, rats treated intracerebroventricularly with streptozotocin (STZ-icv) which enable assessment/follow up of alterations starting immediately after the STZ- induced brain damage. Aims We aimed to explore the acute changes of central cholinergic transmission and insulin system in the STZ-icv rats, measured 1 day, 1 and 2 weeks after the STZ-icv treatment. Methods Adult Wistar rats were administered STZ (0.3-3 mg/kg) or vehicle (controls) icv injections. IR and insulin-degrading enzyme (IDE) protein expression was measured in hippocampus (HPC) by SDS-PAGE electrophoresis and immunoblotting. Acetylcholinesterase (AChE) activity was measured in HPC and parietotemporal cortex (PTC) by Ellman’s method. Data were analysed by Mann- Whitney U test (p<0.05). Results One day after STZ-icv (1 mg/kg) administration hippocampal IR (45.34%) and IDE (30.83%) protein expression was significantly increased as well as AChE activity (26.31%) which after 1 week was normalized in HPC but significantly increased in PTC (23.37%). No clear dose-dependent effect on AChE activity was found with 0.3-3 mg/kg STZ-icv dose range. IR and IDE protein expression in HPC was normalized 2 weeks after STZ-icv (3 mg/kg) administration. Conclusion Cholinergic and insulin brain system are differently affected immediately after STZ-icv induced brain damage ; the former showing immediate but mild onset and development of cholinergic deficit and the latter demonstrating acute, stress-induced response in IR signalling which is compensated during the following two weeks. Acknowledgement Supported by UKF, MZOŠ (108-1080003-0020) and DAAD.

streptozotocin; acetylcholinesterase; sporadic Alzheimer's disease

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

2011.

objavljeno

Podaci o matičnoj publikaciji

Neurodegenerative diseases

Nitsch, Roger M. ; Fisher, Abraham ; Windisch, Manfred ; Hanin, Israel

S.Karger, Medical and Scientific Publisher

978-3-8055-9738-8

Podaci o skupu

The 10th International Conference on Alzheimer's & Parkinson's Diseases

poster

09.03.2011-13.03.2011

Barcelona, Španjolska

Povezanost rada

Temeljne medicinske znanosti